
Frederick Abett Pharmaceuticals Private Limited
About Frederick Abett Pharmaceuticals Private Limited
Data last updated:
Frederick Abett Pharmaceuticals Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 19 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74120UP2015PTC074554. Its GSTIN is 09AACCF6969N1ZS (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.4 Lakh. It is led by directors Dharmendra Rathor and Girish Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21/43E/4 Krishna Colony Jeoni Mandi Thana Chatta, Agra, Uttar Pradesh, India – 282004.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.44 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹44,232 (net margin 1.4%) and EBITDA of ₹87,323 (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Frederick Abett Pharmaceuticals Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address21/43E/4 Krishna Colony Jeoni Mandi Thana Chatta, Agra, Uttar Pradesh, India – 282004
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Frederick Abett Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Frederick Abett Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Frederick Abett Pharmaceuticals Private Limited, buy the company report.
Financials of Frederick Abett Pharmaceuticals Private Limited
FY 2025 filings availableFrederick Abett Pharmaceuticals Private Limited reported revenue of ₹31.44 Lakh (down 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87,323 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44,232 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Frederick Abett Pharmaceuticals Private Limited, buy the company report.
Board of directors of Frederick Abett Pharmaceuticals Private Limited
Frederick Abett Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharmendra Rathor | Director | 19 Nov 2015 | 10 Years 11 Months | Current |
| Girish Agarwal Also directs: Ashokkhandoli Ventures LLP | Director | 19 Nov 2015 | 10 Years 11 Months | Current |
Auditor
Frederick Abett Pharmaceuticals Private Limited is audited by K.G. & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.G. & ASSOCIATES | FY 2017 | 014871C |
Shareholding
The shareholding of Frederick Abett Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Frederick Abett Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Frederick Abett Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Frederick Abett Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Frederick Abett Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCF6969N1ZS | Uttar Pradesh | Active | 26 Jul 2017 |
To see the full GST registrations and return filing status of Frederick Abett Pharmaceuticals Private Limited, buy the company report.
Recent activity
Frederick Abett Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Jugal Singh Rathore ceased to be Director on 06 Jun 2017.
Frequently asked questions
Frederick Abett Pharmaceuticals is an active private limited company based in Agra, Uttar Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 19 November 2015 (11+ years old) and is registered under CIN U74120UP2015PTC074554.
Frederick Abett Pharmaceuticals has 2 current directors:
- Dharmendra Rathor - Director
- Girish Agarwal - Director
The latest financial statements of Frederick Abett Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Frederick Abett Pharmaceuticals is 09AACCF6969N1ZS, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Frederick Abett Pharmaceuticals is U74120UP2015PTC074554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Frederick Abett Pharmaceuticals was incorporated on 19 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kanpur.
Jugal Singh Rathore ceased to be Director on 06 Jun 2017. Sunil Kumar ceased to be Director on 15 May 2017. Amir Khan ceased to be Additional Director on 01 Dec 2016. Frederick Abett Pharmaceuticals has 5 board changes on record in total.
The registered office of Frederick Abett Pharmaceuticals is at 2143E4 Krishna Colony Jeoni Mandi Thana Chatta, Agra, Uttar Pradesh, India – 282004.
Frederick Abett Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Frederick Abett Pharmaceuticals is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.

